Another GLP-1 drug success. Tirzepatide in heart failure with preserved ejection fraction (HFpEF) with longer term follow-up than 2 previous trials with semaglutide https://
nejm.org/doi/full/10.10
56/NEJMoa2410027
… @NEJM #AHA24
in people with BMI >30; no data yet for HFpEF in people without obesity

→ View original post on X — @erictopol,